Aurora Cannabis Inc | ACB

Aurora Cannabis Inc traded at 1.35 this Friday January 27th, increasing 0.06 or 4.65 percent since the previous trading session. Looking back, over the last four weeks, Aurora Cannabis Inc gained 17.39 percent. Over the last 12 months, its price fell by 73.00 percent. Looking ahead, we forecast Aurora Cannabis Inc to be priced at 1.31 by the end of this quarter and at 1.21 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1.35
Daily Change
4.65%
Yearly
-73.00%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
ANI Pharmaceuticals 43.61 0.08 0.18% 10.80%
British American Tobacco 3,036.50 6.50 0.21% -4.04%
Brown Forman Class A 66.41 -0.28 -0.42% -1.25%
Cronos Group Inc 3.30 0.06 1.85% -24.66%
Depomed 4.01 -0.11 -2.67% 75.11%
Imperial Brands PLC 2,012.00 5.00 0.25% 13.90%
Altria 44.14 -0.15 -0.34% -12.56%
Nektar Therapeutics 2.61 0.15 6.10% -75.49%
Philip Morris International 103.76 -0.56 -0.54% 0.23%
Boston Beer 392.29 2.37 0.61% -7.95%
Constellation Brands 228.79 0.29 0.13% -3.08%
Molson Coors Brewing 51.30 -1.47 -2.79% 6.41%
Canopy Growth Corp 3.89 0.21 5.71% -58.08%

Indexes Price Day Year
CATSX 20714 13.98 0.07% -0.13%

Aurora Cannabis Inc
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis derivative products in Canada and internationally. Its segments include Canadian Cannabis, International Cannabis and Bevo. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. It produces approximately 150,000 kilograms (kg) of cannabis biomass annually.